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Abstract 
 
Objectives: to assess two- and three-dimensional changes of the peri-
implant tissues as well as clinical, biological and radiological outcomes of 
implants having been treated with resorbable or non-resorbable 
membranes at 3 years. 
Materials and methods: 
Twenty-three patients were reexamined after having received a single-
tooth implant in the esthetic zone in conjunction with guided bone 
regeneration (GBR) using either a resorbable (RES) or a titanium-
reinforced non-resorbable membrane (N-RES) and demineralized bovine 
bone mineral. Volumetric and linear as well as clinical and radiographic 
measurements were performed at crown insertion (baseline), at one year 
(FU-1) and three years (FU-3).  Statistics were performed by means of 
parametric and non-parametric tests.  
Results:  
Minor, but ongoing buccal volume loss was observed in both groups during 
the 3-year follow-up. A slightly higher volume loss was observed in group 
RES (-0.22mm) compared to N-RES (-0.14mm) at one year (FU-1), but 
aligned at 3 years (FU-3) RES (-0.30mm) N-RES (-0.32mm).  All changes 
over time were statistically significantly different within (p<0.05), but not 
between the groups (p>0.05). Stable median interproximal bone levels 
after 3 years (FU-3); 0.26mm (0.04; 0.36) (RES) and 0.14mm (0.08; 
0.20) (N-RES) and healthy tissues (BOP, PD) were obtained with both 
membranes. 
Conclusions: 
Both treatment modalities resulted in minor, but ongoing contour changes 
of the peri-implant tissues. Stable interproximal bone levels and healthy 
tissues can be obtained with membranes up to 3 years. 
 
  
Introduction 
Guided bone regeneration (GBR) is a frequently applied and well-
documented clinical procedure to regenerate hard tissue deficiencies in 
localized alveolar defects (Benic, Hammerle, 2014). GBR relies on the 
principle of using a barrier membrane with or without supporting bone 
(substitute material) (Dahlin, Linde, Gottlow, Nyman, 1988; Dahlin, 
Sennerby, Lekholm, Linde, Nyman, 1989; Hammerle, Bragger, Schmid, 
Lang, 1998). Various modifications of the original technique were 
evaluated as well as a plethora of materials tested (Esposito, Grusovin, 
Worthington, Coulthard, 2006). In terms of GBR membranes, resorbable 
native collagen membranes and non-resorbable expanded 
polytetrafluorethylen (ePTFE) membranes were most frequently used 
(Esposito, et al., 2009). Both types of membranes offer advantages and 
disadvantages based on the clinical and technical handling, the rate of 
complications and the expected long-term outcomes (Zitzmann, Naef, 
Scharer, 1997). Major advantages of ePTFE membranes include the 
stability of the membrane (Schneider, et al., 2014) per se and long-term 
successful outcomes at dehiscence-type defects. In contrast, resorbable 
collagen membranes offer benefits in terms of no need to remove the 
membrane at second stage surgery, favorable biologic attributes and 
similar long-term performance at dehiscence-type defects (Carpio, Loza, 
Lynch, Genco, 2000; Merli, et al., 2016). (Early) studies, comparing the 
two membranes for bone formation at implant sites revealed similar 
outcomes in terms of the amount of regenerated bone (Zitzmann, et al., 
1997) (Carpio, et al., 2000). More recent evidence however, revealed a 
greater loss of horizontal thickness between implant placement with 
simultaneous GBR and 6 months thereafter when a resorbable membrane 
had been used (Naenni, et al., 2017). Scientific data is controversial 
whether the amount of bone on the buccal side of dental implants 
influences the esthetic outcomes of implants therapy (Merheb, et al., 
2017; Sicilia, et al., 2015). It has even been shown that untreated 
dehiscence defects result in non-inferior outcomes at 1 year compared to 
GBR-treated sites (Jung, et al., 2017). From a clinical point of view, 
biological, radiological and volumetric stability of the peri-implant tissues 
are crucial. To date, scientific data on the stability of the peri-implant 
tissues, comparing dehiscence-type defects using the two membranes, are 
rare. 
The aim of the present study was, therefore, to assess two- and three-
dimensional changes of the peri-implant tissues as well as clinical, 
biological and radiological outcomes of implants having been treated with 
resorbable or non-resorbable membranes at 3 years post insertion of the 
final reconstructions. 
 
Materials and methods 
The present study was designed as a follow-up study of a prospective 
randomized controlled clinical trial (Naenni, et al., 2017) and approved by 
the local ethical committee (Nr. 2010-0051/5). 
 Inclusion criteria 
1. Periodontal healthy patients (periodontal probing depths <4 mm) 
2. Good oral hygiene (full mouth plaque index <25%; (O'Leary, Drake, 
Naylor, 1972) 
3. Adequate control of inflammation (full mouth bleeding on probing 
<25%; (Ainamo, Bay, 1975) 
4. Single-tooth gaps with a buccal alveolar bone deficiency  
5. Planned implant placement >6 weeks after tooth extraction  
6. A buccal bone defect after implant placement 
Patient had to fulfill inclusion criteria prior to surgery (1-5). In case of a 
defect-free implant placement, exclusion could be performed after surgery 
(6). 
 
Surgical protocol 
 Details on the surgical procedures are described in detail in an earlier 
publication (Naenni, et al., 2017). In brief, a full flap was prepared and a 
dental implant (OsseoSpeed, ASTRA TECH Implant System DENTSPLY, 
Mölndal, Sweden) placed in a prosthetically ideal position. A demineralized 
bovine bone mineral (DBBM, BioOss spongiosa granules, particle size 
0.25-1mm; Geistlich Pharma AG, Wolhusen Switzerland) was used to 
augment the dehiscence-type defects. Subsequently, a resorbable 
collagen membrane (BioGide, Geistlich Pharma AG; RES) or a non-
resorbable ePTFE-membrane (Gore-Tex, W.L. Gore & Assoc., Flagstaff, 
Arizona, USA; N-RES) was randomly applied. In the RES group, 
membranes were cut into an overlapping shape of at least 2 mm and then 
fixed buccally by two or three resorbable polylactic acid pins (Inion Pins, 
Geistlich AG, Wolhusen, Switzerland). Membranes in the N-RES group 
were equally shaped, customized extraorally and then stabilized by non-
resorbable titanium pins (Frios, Friadent GmbH, Mannheim, Germany). 
Releasing incisions were made within the periosteum in order to obtain a 
tension-free wound closure using non-resorbabale sutures (Gore-Tex 
sutute; Gore, Flagstaff, AZ, USA). Seven to 10 days after surgery suture 
removal was performed. In case of a soft tissue dehiscence, a strict recall 
interval was performed and patients were advised to apply disinfecting 
agents (Plak Out Gel, Kerr Hawe SA, Bioggio, Switzerland and Solcoseryl, 
Meda Pharma GmbG, Wangen-Brüttisellen, Switzerland). 
Re-entry surgery was performed at 6 months to remove the N-RES 
membrane and the titanium pins and to record the quality and quantity of 
the obtained bone in both groups (N-RES and RES). Abutment connection 
was performed 2 to 4 months later. All implants were restored with final 
reconstructions within four months and a baseline (BL) examination 
scheduled. 
 
Follow-up visits 
At baseline (BL), one year (FU-1) and 3 (FU-3) years, follow-up clinical 
examinations were planned for all patients. 
 
The following parameters were assessed: 
Clinical measurements 
Probing depth (PD) (Ramfjord, 1974), clinical attachment level (CAL), 
plaque control record (PCR) (O'Leary, et al., 1972), and bleeding on 
probing (BOP) (Ainamo, Bay, 1975) at six sites for all implants and the 
two neighboring teeth. Furthermore, at the buccal aspect of all implants, 
the width of the keratinized mucosa was measured. Peri-implant mucositis 
and peri-implantitis were defined as follows: 
1. peri-implant mucositis (clinical signs of inflammation without crestal 
bone loss, PD ≥ 5mm and BOP at >50% of the sites at a given 
implant)  
2. peri-implantitis (mucositis in conjunction with crestal bone loss 
≥2mm) (Mombelli, Lang, 1994)  
 
Radiographic measurements 
Two-dimensional intraoral X-rays at baseline, FU-1 and FU-3 were taken 
using a paralleling technique with rim-holders and digital films. An open-
source software (Image J, National Institutes of Health, Bethesda, 
Maryland USA) was used to assess interproximal marginal bone levels. A 
calibration was performed using the distance between implant threads as 
well as the known implant length and respective diameter.  At the mesial 
and distal aspect of the implant, the distance from the reference point 
(implant shoulder) to the first bone-to-implant contact was measured. 
 
Linear and volumetric outcome measures 
Conventional impressions with an a-silicone material (President, 
Contène/Whaledent Altstätten, Switzerland) were taken at all follow-up 
visits and casts of dental stone class IV were poured. The casts were 
examined meticulously at the relevant site before they were scanned with 
a desktop 3D scanner (Imetric 3D SA, Courgenay, Switzerland). 
Accordingly, the generated stereolithographic files (standard tessellation 
language, STL) were imported into an image analysis software 
(Swissmeda Software, Swissmeda AG, Zurich, Switzerland). All STL files 
(baseline, FU-1, FU-3) of each patient were superimposed using a semi-
automatic algorithm and then manually adjusted according to reference 
structures, mainly teeth, which had not been treated during the 
observation period. This step was double checked and confirmed by an 
additional experienced examiner not part of the study. A region of interest 
(ROI) was defined on the baseline STL-file. The coronal border of the ROI 
followed the mucosal margin of the implant site with a clearance of 1 mm 
and extended 4-5 millimeter apically remaining within the keratinized 
tissue. Mesio-distally, the ROI corresponded to the width of the single-
tooth reconstruction. 
 
Volumetric measurements 
The software then calculated the mean distance (MD) between the 
baseline surface and the FU-1 (MD1) surface as well as between the 
baseline and the FU-3 (MD3) surface. Changes between FU-1 and FU-3 
were calculated by subtraction of the above-described results. 
 
Linear measurements 
A cross-section at the center of the implant crown was selected resulting 
in a representative contour of the buccal peri-implant tissues width (TW). 
Horizontal measurements were carried out at 1 mm (TW1) and at 3 mm 
(TW3) below the buccal mucosal margin. The differences (∆) between the 
absolute ridge width at 1mm (∆TW1) and 3mm (∆TW3) represented the 
changes of the tissue thickness over time. 
 
Statistical analysis 
The primary endpoint was the change in horizontal tissue thickness at the 
buccal aspect of the implant. The secondary endpoints consisted of the 
vertical height of the interproximal bone mesial and distal of the implant; 
the clinical parameters (PD, PCR, BOP), the soft tissue condition 
(thickness of the keratinized mucosa and soft tissue dehiscences). The 
metric variables were described with values in mean, median, standard 
deviation, and quartiles. The categorical measures by frequencies and 
proportions. The statistical comparisons of the group mean for the metric 
variables applied parametric mixed linear models since the data within a 
patient was dependent (clustered). For the comparison of the two groups, 
the nonparametric Wilcoxon-Mann-Whitney test with exact p-value 
determination was applied, due to the small sample size and the data 
distribution. The effects, difference of medians, were estimated by 
Hodges-Lehmann estimates together with its 95% confidence intervals. 
The significance level was set at 5%. No correction was applied for the 
multiple testing since only one primary endpoint was considered. To 
analyze a possible confounding factor (OK/UK) nonparametric 2-way 
ANOVA tests was applied. 
 
Results 
Demographics 
At 3 years, 23 out of 27 patients (11 male, 12 female; mean age 56.6 
years (SD: 17.4) were re-examined. Four patients could not be recalled 
due to the following reasons: one patient had died, three patients had 
moved away. At the time of implant placement all patients had generally 
been healthy. During the observation period three patients had reported 
general medical issues (one heart attack, one osteoporosis, one 
fibromyalgia).  
In the early healing period, five wound dehiscences were observed in the 
RES group and two in group N-RES. One dehiscence (N-RES) persisted 
until the re-entry surgery 6 months after implant placement. No 
membranes were removed prior to the scheduled re-entry time-point and 
no differences in residual defect heights could be detected in neither of 
the two groups. Moreover, dehiscences were not associated with an 
increased residual defect height (Naenni et al. 2016). 
 
Clinical measurements 
Median PD values were stable in both groups over time with minimal 
changes ranging between 3.17mm (Q1: 2.67; Q3: 3.42) at baseline, 
3.00mm (2.83; 3.33) at FU-1 and 3.17mm (2.50; 4.17) at FU-3 for group 
RES. Corresponding median values in group N-RES were 3.00mm (2.67; 
3.67), 3.00mm (2.83; 3.50) and 3.33mm (3.17; 3.67). Median PD values 
for control teeth were smaller when compared to implant sites at all time-
points (Appendix 1). Differences between control teeth and implants were 
statistically significant at all time-points (p=0.0171, p=0.0059, p=0.0068) 
(RES) and (p=0.0313, p=0.0195, p=0.0039) (N-RES). (Appendix 2). 
Mean plaque indices (PCR) were lower at implant sites in both groups at 
all time-points compared to the control teeth. At FU-3, no significant 
differences were observed comparing teeth and implant sites (RES: 
p=0.250; N-RES: p=0.063).  
Median BOP values were higher at implant sites (RES: 27.8%, 33.3%, 
30.3%), (N-RES: 25.9%, 22.2%, 48.1%) compared to natural control 
teeth (RES: 27.1%, 22.0%, 15.2%), (N-RES: 12.7%, 8.3%, 20.0%) at all 
time-points. At 3 years, only the comparison between implant sites in 
group N-RES and natural control teeth was significant (p=0.008). None of 
the differences between the two membrane groups revealed any statistical 
significance (p>0.05). (Appendix 1) 
 
Radiographic measurements 
At baseline, the radiographic assessment demonstrated median 
interproximal marginal bone levels (MBLinterprox) of 0.11mm (-0.07; 
0.46) (RES) and 0.14mm (0.06; 0.19) (N-RES). At FU-1, corresponding 
values were 0.23mm (0.10; 0.41) (RES) and 0.13mm (-0.02; 0.23) (N-
RES) At FU-3, median MBLinterprox measured 0.26mm (0.04; 0.36) 
(RES) and 0.14mm (0.08; 0.20) (N-RES group). All data are displayed in 
Table 1. The differences between RES and N-RES were neither statistically 
significant at BL (p=0.654), FU-1 (p=0.156), FU-3 (p=0.500) nor over 
time (p=0.340; p=0. 853). In addition, the percentage of implants 
demonstrating a MBLinterprox of >1mm was 0 (0%) (RES) and 0 (0%) 
(N-RES) at FU-3.  
 
Volumetric outcome measures 
In general, within the first year after the insertion of the final 
reconstructions, a slightly higher volume loss was observed in group RES 
compared to group N-RES. At FU-3, this difference could no longer be 
observed as expressed by a similar volume change between baseline and 
FU-3 in both groups. The calculated median volume changes at the buccal 
aspect (MD1) were -0.19mm (-0.31; -0.06) (p=0.002; RES) and -0.12mm 
(-0.37; 0.04) (p=0.1855; N-RES) between BL and FU-1. The respective 
changes between baseline and FU-3 (MD3) were -0.31mm (-0.45; -0.07) 
(p=0.00039; RES) and -0.38mm (-0.40; -0.14) (p=0.0078; N-RES). The 
differences between the two groups were not statistically significant 
(p=0.5923; p=0.6685). (Figure 1, Table 2) 
 
Linear outcome measures 
When measuring the horizontal changes at the level 1mm (TW1) and 
3mm (TW3) below the mucosal margin, changes over time (∆TW) were 
minimal in both groups. Changes between baseline and FU-1 were -
0.24mm (-0.42; -0.13) (∆TW1) and -0.33mm (-0.48; -0.15) (∆TW3), at 
between baseline and FU-3 -0.36mm (-0.77; -0.09) and -0.49mm (-0.89; 
-0.22) in group RES. Corresponding values in group N-RES were -0.29mm 
(-0.42; -0.13), -0.24mm (-0.53; -0.17), -0.38mm (-0.44; -0.31) and -
0.60mm (-0.84; -0.30). All changes over time were statistically 
significantly different within (p<0.05), but not between the groups 
(p>0.05) (Figure 2, Table 3). 
 
Discussion 
The present follow-up study evaluating linear and volumetric changes of 
the peri-implant tissues as well peri-implant health of implant sites with 
buccal guided bone regeneration demonstrated:  
i) a minimal, but continuous decrease of the buccal contour 
between the insertion of the final reconstruction and 3 years,  
ii) no difference for any of the outcome measures between sites 
treated with resorbable or non-resorbable membranes at the 3-
year follow-up. 
iii) higher PD and BOP values around dental implants compared to 
natural teeth at 3 years. 
 
Long-term outcomes focusing not only on implant survival, but also on  
the success of dental implants have been the focus of intensive research 
lately (Hjalmarsson, Gheisarifar, Jemt, 2016). Recently published 
systematic reviews have focused both on the stability of augmented sites 
(Merli, et al., 2016) and esthetic outcomes (Chen, Buser, 2014). Although 
basic mechanisms of remodeling at extraction sites and at dental implants 
seem to be understood (Chen, Beagle, Jensen, Chiapasco, Darby, 2009); 
there is still a lack of information on the stability of the buccal contour 
following GBR procedures.  
Stability and changes thereof are both dependent on the underlying hard 
and soft tissues. According to current literature, the average bone 
thickness after GBR at the cervical aspect of dental implant measures 
approximately 1.56 mm (Miyamoto, Obama, 2011) and increases to 
2.2mm in the middle section (Buser, et al., 2013; Miyamoto, Obama, 
2011).  Over time, remodeling processes influence these dimensions and 
areas without radiologically detectable bone at the buccal aspect of the 
implant are no exception (Benic, et al., 2012; Kuchler, Chappuis, Gruber, 
Lang, Salvi, 2016; Miyamoto, Obama, 2011).  Surprisingly, these findings 
are only associated with recessions ≤1mm of the buccal soft tissues. Thin 
bone wall phenotypes (<1mm) tend to show a more progressive 
resorption pattern, whereas the facial soft tissue thickness seems not 
correlate with the bone wall dimension underneath (Chappuis, Araujo, 
Buser, 2017). Soft tissue grafting procedures for volume gain might 
compensate for ongoing changes of the hard tissues, but scientific 
evidence is missing.  
With the recently developed, non-invasive technique to evaluate 
volumetric changes, (De Bruyckere, Eghbali, Younes, De Bruyn, Cosyn, 
2015; Sanz Martin, Benic, Hammerle, Thoma, 2016; Schneider, Grunder, 
Ender, Hammerle, Jung, 2011) even small changes can be detected. This 
accurate and adequate procedure proved to be successful and precise in 
analyzing volumetric changes of tissues over time based on various 
preclinical and clinical studies (Bienz, et al., 2017; Schneider, et al., 2011; 
Thoma, et al., 2010) 
Even though, the dimensional changes in the present study are small (less 
than 0.4mm in both groups), a possible continuity of ongoing volume 
changes might cause esthetic problems in the future. The findings of the 
present study demonstrating a loss of the buccal contour up to 3 years 
post loading are not in line with a recently published study (Buser, et al., 
2013). In that particular clinical study, stable volumes of the buccal 
contour were found. In contrast to the present study, longer-term 
outcomes were evaluated by using CBCTs or esthetic scores. One has to 
bear in mind, however, that these scores are subjectively assessed using 
a grading system and report no absolute values. In general, the most 
frequently used parameters for the assessment of peri-implant mucosal 
esthetics are the vertical position of the buccal mucosal margin and the 
height of the interproximal papillae (Benic, et al., 2012). A drawback of 
this assessment method is the fact that these parameters do not take the 
buccal contour into account. 
According to a recently published systematic review (Lutz, Neukam, 
Simion, Schmitt, 2015), more longer-term studies were demanded with a 
focus on three-dimensional changes of the buccal tissues using non-
invasive methods, since smaller changes might not be detected by the 
naked eye. In a 5-year follow-up of 33 patients, volumetric and linear 
changes of the peri-implant tissues were evaluated (Sapata, et al.). One 
of the most important outcomes, assessed in that study, was the 
comparison of contour changes between implant sites and natural control 
teeth. Up to the 1-year follow-up, natural control teeth lost 0.08mm less 
in comparison to implants without being statistically significant. Up to the 
5-year follow-up, a mean loss of -0.07 to -0.1 mm/year was recorded. 
The volume differences between implants and natural teeth amounted to -
0.08(±0.21) mm (baseline to 1 year), -0.30(±0.47) mm (baseline to 5 
years) and -0.20(±0.35) mm (1 year to 5 years). These data are 
comparable to the present study, revealing a yearly loss of –0.1mm in 
group RES and of -0.12 mm in group N-RES.  
 
The two study groups only differed in terms of the membrane used to 
perform GBR. At implant placement, the horizontal bone thickness 
amounted to 3.46 mm (±0.52) (RES) and 2.82 mm (±0.50) (N-RES) 
(Naenni, et al., 2017). Even though more soft tissue dehiscences had 
occurred in group RES, no membranes had to be prematurely removed. At 
6 months, when reentry was performed in both groups conducting a full 
thickness flap in order to remove the membrane (N-RES group) and to 
measure the buccal contour (RES and N-RES). At this time-point bone was 
present on the buccal surface of all implants at all sites. Soft tissue 
dehiscences were not associated with an increased residual defect height, 
which is in line with a previous publication (Zitzmann et al. 1997). The 
horizontal bone loss, however, was significantly different in favor of group 
N-RES 0.14mm (±0.79) (compared to group RES with 2.23 mm (±1.21)). 
In the present study, a new baseline at the time of crown insertion was 
defined to evaluate the longer-term stability of the peri-implant tissues 
and the buccal contour.  Interestingly, up to FU-1, group N-RES (-0.14) 
showed less mean volume shrinkage compared to group RES (-0.22). Up 
to 3 years, however, no significant differences were observed between the 
two groups (N-RES (-0.32) and RES (-0.30)). These observations highlight 
that contour changes of the peri-implant tissues are ongoing even after 
crown insertion and that these remodeling processes may be influenced 
by the materials used for the GBR procedure.  Similar observations were 
reported in a recent systematic reviews (Merli, et al., 2016). 
 
Apart from linear and volumetric changes of the contour, the health of the 
peri-implant tissues as well as the comparison to natural control teeth 
over time are of importance. Median PD values were stable over time (FU-
1, FU-3) in both groups. The comparison of PD values between implants 
and control teeth, however, was significant at all time-points and in both, 
the resorbable and non-resorbable membrane group. At implant sites, the 
barrier epithelium with a dimension of 2 mm and a 1.3-1.8 mm zone of 
connective tissue define the biologic width (Berglundh, Lindhe, 1996), 
roughly measuring 3.8mm. For natural teeth, the dimension of the 
dentogingival unit is reported to be 2.7mm (Gargiulo, Wentz, Orban, 
1960; Vacek, Gher, Assad, Richardson, Giambarresi, 1994). Differences 
between implant sites and natural teeth were explained by the lack of 
Sharpey’s fibres at implant sites, allowing the probe to penetrate closer to 
the bone crest (Berglundh, Lindhe, 1996). In a multi-level analysis of 
associated factors, tooth data from 601 healthy adults were 
retrospectively analyzed (Farina, Tomasi, Trombelli, 2013). An overall 
probability of 21% (0.21; 95% CI: 0.19-0.23) for sites to be BOP positive 
was detected. These findings are in accordance with the results of the 
study, demonstrating median BOP values of 30.5% (RES), 32.1% (N-RES) 
and 13.7% for control teeth. The data thereby underline, that implant 
sites are associated with higher BOP values, without reaching substantial 
differences compared to control teeth. 
 
 
Conclusions 
Within the limits of this clinical study it can be concluded that, at 3 years 
of function, dental implants with simultaneously performed GBR using 
either a resorbable or non-resorbable membranes, result in: 
- a minor (less than 0.4mm in both groups), but ongoing loss of the 
buccal contour.  
- a similar buccal contour at 1 year and similar contour changes up to 3 
years.  
-stable interproximal bone levels and healthy tissue using both 
membranes up to 3 years. 
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Figure legends 
Figure 1. Clinical Situation and corresponding volumetric outcome 
measures; Fig 1(a-c) example of N-RES group at (a) BL, (b) FU-1 , (c) FU-
3); Fig 1(d-f) example of RES group at (d) BL, (e) FU-1, (f) FU-3; BL= 
baseline (yellow), FU-1= 1-year follow-up (green), FU-3= 3-year follow up 
(grey), RES= resorbable membrane, N-RES= titanium-reinforced non-
resorbable membrane, ROI= region of interest (orange). 
 Figure 2.  (a) Cross-section of buccal contour in the N-RES group and (b) 
in the RES group. Differences of tissue thickness were analysed at 1 and 3 
mm below the mucosal margin (scale). The differences between baseline 
(yellow), FU-1 (green) and FU-3 (grey) were measured. For volumetric 
measurements, the region of interest (ROI) (orange) was compared at 
different time-points (BL, FU-1, FU-3); BL= baseline, FU-1= 1-year follow-
up, FU-3= 3-year follow up, RES= resorbable membrane, N-RES= 
titanium-reinforced non-resorbable membrane 
 
 
Table 1. Descriptive data of two dimensional x-ray for interproximal 
marginal bone levels (MBLinterprox); p-values between the groups, BL= 
baseline, FU-1= 1-year follow-up, FU-3= 3-year follow up, RES= 
resorbable membrane, N-RES= titanium-reinforced non-resorbable 
membrane 
 
Table 2. Volumetric outcome measures; MD1= the calculated median 
volume changes at the buccal aspect between baseline and one year 
follow up, MD3= the calculated median volume changes at the buccal 
aspect between baseline and three year follow up, RES= resorbable 
membrane, N-RES= titanium-reinforced non-resorbable membrane, p-
values between the groups 
 
Table 3. Linear outcome measures; TW= tissue width of the peri-implant 
contour at 1 mm (TW1) and at 3 mm (TW3) below the buccal mucosal 
margin; Differences (∆) between the absolute ridge width at 1mm (∆TW1) 
and 3mm (∆TW3); RES= resorbable membrane; N-RES= titanium-
reinforced non-resorbable membrane; p-values between the groups 
 
Appendix 1. Clinical measurements; BL= baseline, FU-1= 1-year follow-
up, FU-3= 3-year follow up, RES= resorbable membrane, N-RES= 
titanium-reinforced non-resorbable membrane, PD= probing depth, BOP= 
bleeding on probing, PCR= plaque control record 
 
Appendix 2. Differences of clinical measurements between implant sites 
and control teeth; BL= baseline, FU-1= 1-year follow-up, FU-3= 3-year 
follow up, RES= resorbable membrane, N-RES= titanium-reinforced non-
resorbable membrane, PD= probing depth, BOP= bleeding on probing, 
PCR= plaque control record 
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Table 2:  
 
 
 
 
 
 
 
 
 
 
 
 
 RES N-RES p-
value  Mean ± SD Median Q1 ; Q3 Mean ± SD Median Q1 ; Q3 
BL 0.23 ± 0.49 0.11 -0.07 ; 0.46 0.12 ± 0.09 0.14 0.06 ; 0.19 0.654 
FU-1 0.23 ± 0.19 0.23 0.10 ; 0.41 0.10 ± 0.17 0.13 -0.02 ; 0.23 0.156 
FU-3 0.19 ± 0.21 0.26 0.04 ; 0.36 0.16 ± 0.10 0.14 0.08 ; 0.20 0.500 
 RES N-RES p-value 
 Mean ± SD Median Q1 ; Q3 p-value Mean ± SD Median Q1 ; Q3 p-value 
MD1 -0.22 ± 0.21 -0.19 -0.31 ; -0.06 0.0020 -0.14 ± 0.30 -0.12 -0.37 ; 0.04 0.1855 0.5923 
MD3 -0.30 ± 0.25 -0.31 -0.45 ± -0.07 0.0039 -0.32 ± 0.22 -0.38 -0.40 ; -0.14 0.0078 0.6685 
 
 
Table 3:  
  
RES N-RES 
p-value 
  Mean ± SD Median Q1 ; Q3 p-value Mean ± SD Median Q1 ; Q3 p-value 
TW1 ∆TW1 -0.28 ± 0.29 -0.24 -0.42 ; -0.13 0.0068 -0.28 ± 0.23 -0.29 -0.42 ; -0.13 0.0195 0.7804 
∆TW3 -0.41 ± 0.38 -0.33 -0.48 ; -0.15 0.0010 -0.37 ± 0.14 -0.38 -0.44 ; -0.31 0.0039 0.7804 
TW3 ∆TW1 -0.37 ± 0.42 -0.36 -0.77 ; -0.09 0.0244 -0.37 ± 0.29 -0.24 -0.53 ; -0.17 0.0039 0.9571 
∆TW3 -0.56 ± 0.33 -0.49 -0.89 ; -0.22 0.0010 -0.59 ± 0.30 -0.60 -0.84 ; -0.30 0.0039 0.7525 
 
 
 
 
  
 
 
 
Appendix 1: 
 
  RES N-RES 
  Mean ± SD Median Q1 ; Q3  Mean ± SD Median Q1 ; Q3 
PD 
BL 3.18 ± 1.08 3.17 2.67 ; 3.42 3.11 ± 0.67 3.00 2.67 ; 3.67 
FU-1 3.23 ± 0.89 3.00 2.83 ; 3.33 3.19 ± 0.64 3.00 2.83 ; 3.50 
FU-3 3.26 ± 0.86 3.17 2.50 ; 4.17 3.39 ± 0.49 3.33 3.17 ; 3.69 
 BOP 
BL 0.28 ± 0.27 0.17 0.08 ; 0.42 0.26 ± 0.30 0.17 0.17 ; 0.33 
FU-1 0.33 ± 0.27 0.33 0.00 ; 0.67 0.22 ± 0.12 0.17 0.17 ; 0.33 
FU-3 0.30 ± 0.21 0.33 0.17 ; 0.50 0.48 ± 0.27 0.33 0.33 ; 0.50 
PCR 
BL 0.11 ± 0.16 0.00 0.00 ; 0.17 0.07 ± 0.17 0.00 0.00 ; 0.50 
FU-1 0.05 ± 0.08 0.00 0.00 ; 0.17 0.11 ± 0.14 0.00 0.00 ; 0.17 
FU-3 0.11 ± 0.20 0.00 0.00 ; 0.17 0.06 ± 0.12 0.00 0.00 ; 0.33 
 
  
 
 
 
Appendix 2: 
 
  RES / Control N-RES / Control 
  Mean ± SD Median Q1 ; Q3 p-value Mean ± SD Median Q1 ; Q3 p-value 
PD 
BL 0.73 ± 1.15 0.67 0.21 ; 0.88 0.017 0.60 ± 0.59 0.50 0.17 ; 1.08 0.031 
FU-1 0.78 ± 0.80 0.58 0.33 ; 1.33 0.006 0.66 ± 0.635 0.58 0.17 ; 1.00 0.020 
FU-3 0.74 ± 0.72 0.75 0.25 ; 1.17 0.007 0.91 ± 0.43 0.83 0.75 ; 1.17 0.004 
BOP BL 0.28 ± 0.27 0.17 0.08 ; 0.42 0.969 0.15 ± 0.34 0.08 -0.08 ; 0.17 0.383 
FU-1 0.33 ± 0.27 0.33 0.00 ; 0.67 0.127 0.14 ± 0.13 0.17 0.08 ; 0.17 0.023 
FU-3 0.31 ± 0.21 0.33 0.17 ; 0.50 0.068 0.30 ± 0.24 0.25 0.17 ; 0.42 0.008 
PCR BL -0.08 ± 0.12 -0.13 -0.17 ; 0.00 0.033 -0.22 ± 0.18 -0.25 -0.33 ; -0.08 0.016 
FU-1 -0.11 ± 0.11 -0.08 -0.17 ; -0.00 0.016 -0.05 ± 0.20 0.00 -0.08 ; 0.08 0.656 
FU-3 -0.10 ± 0.24 -0.08 -0.25 ; 0.00 0.25 -0.14 ± 0.20 -0.08 -0.17 ; 0.00 0.063 
 
